These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8296581)

  • 1. Prospective evaluation of the serotonin syndrome in depressed inpatients treated with clomipramine.
    Lejoyeux M; Rouillon F; Adès J
    Acta Psychiatr Scand; 1993 Nov; 88(5):369-71. PubMed ID: 8296581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The serotonin syndrome: review of the literature and description of an original study].
    Lejoyeux M; Rouillon F; Léon E; Adès J
    Encephale; 1995; 21(5):537-43. PubMed ID: 8529562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The serotonin syndrome.
    Lejoyeux M; Fineyre F; Adès J
    Am J Psychiatry; 1992 Oct; 149(10):1410-1. PubMed ID: 1530086
    [No Abstract]   [Full Text] [Related]  

  • 4. Serotonin syndrome during clomipramine and lithium treatment.
    Kojima H; Terao T; Yoshimura R
    Am J Psychiatry; 1993 Dec; 150(12):1897. PubMed ID: 8238650
    [No Abstract]   [Full Text] [Related]  

  • 5. Serotonin Syndrome After an Alcohol Intake in a Patient Treated With Escitalopram and Clomipramine.
    Suzuki A; Otani K
    Clin Neuropharmacol; 2019; 42(3):103-104. PubMed ID: 30844852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of clomipramine treatment on cerebrospinal fluid monoamine metabolites and platelet 3H-imipramine binding and serotonin uptake and concentration in major depressive disorder.
    Mårtensson B; Wägner A; Beck O; Brodin K; Montero D; Asberg M
    Acta Psychiatr Scand; 1991 Feb; 83(2):125-33. PubMed ID: 1708190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noradrenergic and serotoninergic depression?
    Yazici O; Aricioğlu F; Gürvit G; Uçok A; Taştaban Y; Canberk O; Ozgüroğlu M; Durat T; Sahin D
    J Affect Disord; 1993 Feb; 27(2):123-9. PubMed ID: 8382710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Psychopathologic and psychophysiologic follow-up of inpatient depressed patients with standardized treatment with clomipramine and oxaprotiline].
    Steiner B; Wolfersdorf M; Keller F; Straub R; Hole G
    Schweiz Arch Neurol Psychiatr (1985); 1991; 142(3):259-69. PubMed ID: 1713352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin syndrome during clomipramine monotherapy: comparison of two diagnostic criteria.
    Kudo K; Sasaki I; Tsuchiyama K; Akiyoshi J; Nagayama H; Fujii I
    Psychiatry Clin Neurosci; 1997 Feb; 51(1):43-6. PubMed ID: 9076860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cortical serotonin2 receptors studied with positron-emission tomography and [18F]-setoperone during depressive illness and antidepressant treatment with clomipramine.
    Attar-Lévy D; Martinot JL; Blin J; Dao-Castellana MH; Crouzel C; Mazoyer B; Poirier MF; Bourdel MC; Aymard N; Syrota A; Féline A
    Biol Psychiatry; 1999 Jan; 45(2):180-6. PubMed ID: 9951565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nocturnal cataclysms with myoclonus: a new side effect of clomipramine.
    Myers BA; Klerman GL; Hartmann E
    Am J Psychiatry; 1986 Nov; 143(11):1490-1. PubMed ID: 3777258
    [No Abstract]   [Full Text] [Related]  

  • 12. Toxic neonatal effects following maternal clomipramine therapy.
    Schimmell MS; Katz EZ; Shaag Y; Pastuszak A; Koren G
    J Toxicol Clin Toxicol; 1991; 29(4):479-84. PubMed ID: 1749054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible development of the serotonin syndrome in man.
    Insel TR; Roy BF; Cohen RM; Murphy DL
    Am J Psychiatry; 1982 Jul; 139(7):954-5. PubMed ID: 7091416
    [No Abstract]   [Full Text] [Related]  

  • 14. CGP 12.103 A versus clomipramine in the treatment of depressed inpatients--results of a double-blind study.
    Wolfersdorf M; Wendt G; Binz U; Steiner B; Hole G
    Pharmacopsychiatry; 1988 Jul; 21(4):203-7. PubMed ID: 3060885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Jerk-locked averaging and somatosensory evoked potential in tricyclic-induced myoclonus: a case report.
    Fukuzako H; Hokazono Y; Tominaga H; Hirakawa K; Matsumoto K
    Jpn J Psychiatry Neurol; 1989 Dec; 43(4):645-9. PubMed ID: 2637391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myoclonic movements as a side-effect of treatment with therapeutic doses of clomipramine.
    Casas M; Garcia-Ribera C; Alvarez E; Udina C; Queralto JM; Grau JM
    Int Clin Psychopharmacol; 1987 Oct; 2(4):333-6. PubMed ID: 3693873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin reuptake inhibitors, epilepsy and myoclonus.
    Deahl M; Trimble M
    Br J Psychiatry; 1991 Sep; 159():433-5. PubMed ID: 1958958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind study of oxaprotiline versus clomipramine in the treatment of depressive inpatients.
    Wolfersdorf M; Binz U; Wendt G; Metzger R; Hole G
    Neuropsychobiology; 1987; 17(1-2):41-8. PubMed ID: 3306439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of serotonin syndrome].
    Loza B
    Psychiatr Pol; 1995; 29(4):529-38. PubMed ID: 7568525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of clomipramine and doxepin in neurotic depression.
    Kornhaber A; Horwitz IM
    J Clin Psychiatry; 1984 Aug; 45(8):337-41. PubMed ID: 6378895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.